tradingkey.logo
tradingkey.logo
Search

Collplant Biotechnologies Ltd

CLGN
Add to Watchlist
3.970USD
-0.070-1.73%
Market hours 09/24, 09:50ET
75.07MMarket Cap
LossP/E TTM

Collplant Biotechnologies Ltd (CLGN) Stock Price Target & Forecast

Target Price
11.000USD+3556.91%

CLGN Analyst Recommendation Trends

In the current month, CLGN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CLGN average Analyst price target in the last month is 11.000.

2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
Strong Buy
0
0
0
0
0
0
0
0
Buy
0
0
0
0
1
1
1
2
Hold
0
0
0
0
0
1
1
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
0
0
0
0
1
2
2
2

CLGN Analyst Rating for Peer Comparison

Updated: Sep 23, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20

Financial Forecasting

Based on analysts' estimates, CLGN EPS is projected to reach 0.350 in FY2026Q2, following reported EPS of -2.253 in FY2026Q1. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q3
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
Forecast
1.55
-1.90
-0.19
0.35
-0.20
Actual
-2.74
-2.51
-2.25
--
--
Surprise
-276.63%
-32.01%
-1085.68%
--
--

FAQs

What is Collplant Biotechnologies Ltd's expected revenue for the next quarter?

Collplant Biotechnologies Ltd's expected revenue is 9.80M.

What is Collplant Biotechnologies Ltd's price target?

Analysts forecast that Collplant Biotechnologies Ltd's price target is USD 11.00, with the highest forecast at USD 11.00 and the lowest forecast at USD 11.00.

How have Collplant Biotechnologies LtdCLGN's recent earnings per share performed?

The market expectation was USD -2.25, while Collplant Biotechnologies LtdCLGN's earnings per share (EPS) for the previous quarter was USD -2.51. EPS for the next quarter is expected at USD 0.35.

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.